Literature DB >> 24116395

Bilateral stereotactic radiofrequency amygdalohippocampectomy for a patient with bilateral temporal lobe epilepsy.

Huimin Luo1, Quanjun Zhao, Zengmin Tian, Zhaohui Wu, Fuli Wang, Hong Lin, Feng Yin, Hulin Zhao, Xia Xiao, Xue Yu, Haiying Wang, Hongxi Zhao, Changlan Cai.   

Abstract

To search for a method for treatment of bilateral temporal lobe epilepsy (BTLE), we report one patient with BTLE experienced bilateral stereotactic radiofrequency amygdalohippocampectomy (SAHE). Neuropsychological examinations were performed before and 5 days, and 6, 18, and 48 months after operation. No seizure occurred in the follow-up time, and no long-term memory and intelligence deficits were found except for a transient decline of the scores immediately after operation. Because severe damage of memory could be caused by bilateral resection surgery, bilateral SAHE should be considered as a possible approach for the treatment of BTLE. However, further studies with accumulation of cases are needed, especially in the detailed assessment of neuropsychological function. Wiley Periodicals, Inc.
© 2013 International League Against Epilepsy.

Entities:  

Keywords:  Bilateral temporal lobe epilepsy; Neuropsychological examination; Stereotactic radiofrequency amygdalohippocampectomy

Mesh:

Year:  2013        PMID: 24116395     DOI: 10.1111/epi.12387

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  2 in total

1.  DTI-based response-driven modeling of mTLE laterality.

Authors:  Mohammad-Reza Nazem-Zadeh; Kost Elisevich; Ellen L Air; Jason M Schwalb; George Divine; Manpreet Kaur; Vibhangini S Wasade; Fariborz Mahmoudi; Saeed Shokri; Hassan Bagher-Ebadian; Hamid Soltanian-Zadeh
Journal:  Neuroimage Clin       Date:  2015-10-30       Impact factor: 4.881

2.  Bilateral stereotactic lesions and chronic stimulation of the anterior thalamic nuclei for treatment of pharmacoresistant epilepsy.

Authors:  A R Sitnikov; Yu A Grigoryan; L P Mishnyakova
Journal:  Surg Neurol Int       Date:  2018-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.